Nostrum Biodiscovery provides computational molecular modeling and AI-powered molecular design services and software for pharmaceutical and biotech companies, CROs, and academic groups. Its proprietary PELE algorithm and generative AI models support de novo design and optimization of small molecules, proteins, enzymes, antibodies, peptides, and nucleic acids. The company also offers licensing of its software and collaborative co-development with shared IP.